Invasion inhibition in pancreatic cancer using the oral iron chelating agent deferasirox

Lignende værker

• Invasion inhibition in pancreatic cancer using the oral iron chelating agent deferasirox
  af: Amano, Shogo, et al.
  Udgivet: (2020)
• Deferasirox, an oral iron chelator, with gemcitabine synergistically inhibits pancreatic cancer cell growth in vitro and in vivo
  af: Shinoda, Shuhei, et al.
  Udgivet: (2018)
• Deferasirox, a novel oral iron chelator, shows antiproliferative activity against pancreatic cancer in vitro and in vivo
  af: Harima, Hirofumi, et al.
  Udgivet: (2016)
• Deferasirox, an oral iron chelator, prevents hepatocarcinogenesis and adverse effects of sorafenib
  af: Yamamoto, Naoki, et al.
  Udgivet: (2016)
• Effects of an oral iron chelator, deferasirox, on advanced hepatocellular carcinoma
  af: Saeki, Issei, et al.
  Udgivet: (2016)